Gilead Rips Merck’s New Bid To Restore $2.5B Patent Verdict

Gilead Sciences Inc. urged the Federal Circuit on Thursday to nix a Merck & Co. subsidiary’s bid for the full court to review a panel decision that wiped out a $2.5 billion verdict in a patent dispute, calling the Merck unit’s “attacks” on the panel’s ruling “an exercise in selective omission”…

Read this piece in its entirety at Law360.


Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s